Results 131 to 140 of about 5,700 (203)

Effectiveness of a mobile respiratory trainer (AiroFit PRO^™) in ankylosing spondylitis: a randomized controlled trial. [PDF]

Ann Med
Uçar Baytaroğlu İM, Karahan AY.
europepmc   +1 more source

Association between SARC-F as a self-report screening tool for sarcopenia and muscle strength, physical performance, daily activity, patient-reported outcomes and body composition in patients with spondyloarthritis. [PDF]

RMD Open
Kononenko J, Bedei M, Buehring B, Kiefer D, Redeker I, Baraliakos X, Kiltz U.   +6 more
europepmc   +1 more source

Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression. [PDF]

RMD Open
Cuesta-López L, Arias-de la Rosa I, Pérez-Sánchez C, Barbera-Betancour A, Ruiz-Ponce M, Barranco AM, Ortiz-Buitrago P, Ladehesa-Pineda L, Puche-Larrubia MÁ, Martín-Salazar JE, Moreno-Caño E, Ábalos-Aguilera MC, Lopez-Pedrera C, Escudero-Contreras A, Collantes-Estévez E, López-Medina C, Barbarroja N.   +16 more
europepmc   +1 more source

Ivarmacitinib improves patient-reported outcomes across multiple domains in patients with active ankylosing spondylitis: a <i>post hoc</i> analysis of a phase II/III trial. [PDF]

Front Pharmacol
Xu X, Wei H, Liu L, Yang R, Shi Q, Pang D.   +5 more
europepmc   +1 more source

Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome. [PDF]

Arthritis Res Ther
Bertsias A, Flouri I, Emmanouilidou E, Repa A, Avgoustidis N, Kalogiannaki E, Pitsigavdaki S, Bertsias G, Sidiropoulos P.   +8 more
europepmc   +1 more source

Anti-CD74 IgA as a potential biomarker in axial spondyloarthritis: diagnostic utility and clinical implications. [PDF]

Clin Rheumatol
Ammar GEM, Eldeeb AE, Mourad HA, Tabra SA.   +3 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort. [PDF]

Arch Rheumatol
Bakay U, İzci Duran T.
europepmc   +1 more source

The impact of nurse-led disease management education on outcomes of patients with ankylosing spondylitis: a randomised controlled trial. [PDF]

J Res Nurs
Dağ A, Tulek Z, Seyahi E.
europepmc   +1 more source

Erosive costovertebral joint arthritis as a novel feature of ankylosing spondylitis. [PDF]

Quant Imaging Med Surg
Zhang S, Dai X, Xu S, Wang Q, Wang S.
europepmc   +1 more source

Impact of symptom duration on the short- and long-term efficacy of bimekizumab in axial spondyloarthritis: results up to 2 years. [PDF]

Arthritis Res Ther
Ramiro S, Proft F, Sengupta R, van Tubergen A, Moltó A, Gensler LS, Kishimoto M, Taieb V, Kavanagh S, Evans S, Navarro-Compán V.   +10 more
europepmc   +1 more source